53217-0300 Ondansetron

Product NDC:

53217-0300

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 8.0

Unit: mg/1

Packages:

Code: 53217-0300-05

Description: 5 TABLET, FILM COATED in 1 BOTTLE (53217-300-05)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-06

Description: 6 TABLET, FILM COATED in 1 BOTTLE (53217-300-06)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-10

Description: 10 TABLET, FILM COATED in 1 BOTTLE (53217-300-10)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-12

Description: 12 TABLET, FILM COATED in 1 BOTTLE (53217-300-12)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-13

Description: 4 TABLET, FILM COATED in 1 BOTTLE (53217-300-13)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-15

Description: 15 TABLET, FILM COATED in 1 BOTTLE (53217-300-15)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-20

Description: 20 TABLET, FILM COATED in 1 BOTTLE (53217-300-20)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-30

Description: 30 TABLET, FILM COATED in 1 BOTTLE (53217-300-30)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-31

Description: 3 TABLET, FILM COATED in 1 BOTTLE (53217-300-31)

Effective Date: June 25, 2007

Discontinued:

Code: 53217-0300-60

Description: 60 TABLET, FILM COATED in 1 BOTTLE (53217-300-60)

Effective Date: June 25, 2007

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC